What is Urology?

Urology: Urinary & Reproductive Disease Diagnosis & Treatment

Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Anatomy and Embryology: The Male Reproductive Cornerstone

Prostate Diseases

The prostate gland is a hormone-regulated organ made of muscle and gland tissue, found only in biological males. It sits where the urinary and reproductive tracts meet, which is why prostate problems often affect urination. The prostate is deep in the pelvis, just below the bladder neck and above the urogenital diaphragm, which holds the external urinary sphincter.

The prostate is shaped like an upside-down cone or a chestnut. Its base connects to the bladder neck, and its tip rests on the pelvic floor muscles. The gland is wrapped in a fibrous capsule, with another layer of pelvic fascia outside it. Between these layers is a network of veins called Santorini’s plexus, which is important during surgery. Behind the prostate, a layer called Denonvilliers’ fascia separates it from the rectum. This barrier helps prevent prostate cancer from spreading to the rectum and allows doctors to feel the back of the prostate during a Digital Rectal Examination (DRE).

The prostate starts to form between the 10th and 12th week of pregnancy. It develops from small buds in the urogenital sinus, influenced by fetal androgens. These buds grow into the surrounding tissue, which becomes the muscle and support structure of the gland. This early interaction is important for both normal development and for conditions like benign prostatic hyperplasia (BPH) later in life, which may reactivate these early growth pathways.

The prostatic urethra runs straight through the center of the prostate, bending slightly at the verumontanum, where the ejaculatory ducts enter. Because of this, when the prostate grows in the center, it can press on the urinary passage. Urinary control depends on two sphincters: the internal one at the bladder neck, which works automatically, and the external one at the tip of the prostate, which you control voluntarily. Prostate surgery can affect the internal sphincter, so protecting the external sphincter is key to keeping continence after surgery.

The Neurovascular Bundles Running along the posterolateral aspect of the prostate capsule (at the 5 o’clock and 7 o’clock positions) are the cavernous nerves, collectively termed the neurovascular bundles. These microscopic parasympathetic fibers originate from the pelvic plexus and are responsible for inducing penile erection. Their intimate proximity to the prostate capsule makes them highly vulnerable during radical prostatectomy. Understanding this anatomy is fundamental to the concept of “Nerve-Sparing” surgery, a technique refined at Liv Hospital to preserve sexual potency.

The prostate is made up of different zones, not just one type of tissue. In 1968, John McNeal introduced the idea of zonal anatomy for the prostate. Each zone develops differently, has its own tissue structure, and is prone to certain diseases.

  • The Peripheral Zone makes up about 70% of the prostate in healthy young men. It wraps around the end of the urethra and extends to the back and sides. Most prostate cancers (70-80%) start in this zone. Since it forms the back of the prostate, tumors here can be felt during a rectal exam and are easy to reach for a biopsy.
  • The Transition Zone (TZ): Originally constituting only 5% to 10% of the glandular tissue, this zone consists of two bilateral lobes surrounding the proximal urethra. The Transition Zone is the exclusive site of origin for Benign Prostatic Hyperplasia (BPH). As men age, hyperplastic nodules originating here expand exponentially, compressing the Peripheral Zone outward into a thin, fibrous shell known as the “surgical capsule.”
  • The Central Zone makes up about 25% of the prostate and is shaped like a cone around the ejaculatory ducts, which pass through the prostate to the urethra. This zone comes from the Wolffian ducts during development. Cancers in this area are rare (1-5%) but are usually more aggressive when they happen.

The Anterior Fibromuscular Stroma is a layer of dense muscle and fibrous tissue that covers the front of the prostate. It does not have gland cells, so cancers rarely start here. However, large tumors from the Transition Zone can grow into this area, which makes them hard to detect during a rectal exam.

Icon LIV Hospital

Physiology and Function

The prostate is an exocrine gland whose function is tightly regulated by the endocrine system. Its primary biological mandate is reproductive. It secretes prostatic fluid, a milky, alkaline substance that constitutes approximately 30% of the total volume of semen. This fluid is biologically complex and essential for male fertility.

  • Alkalinity and pH Regulation: The vaginal environment is naturally acidic (pH 3.5-4.5) to prevent infection. This acidity is toxic to sperm. Prostatic fluid is alkaline (pH 7.2-7.6), neutralizing the vaginal acidity immediately upon ejaculation, thereby ensuring sperm survival and motility.
  • Liquefaction: Immediately after ejaculation, semen coagulates into a gel to adhere to the cervix. Proteins from the seminal vesicles drive this coagulation. The prostate secretes Prostate-Specific Antigen (PSA), a serine protease enzyme (kallikrein-3). PSA breaks down the gel matrix (seminogelins) over 15 to 30 minutes, a process called liquefaction, releasing the sperm so they can swim freely into the uterus.
  • Zinc and Antibacterial Defense: The prostate accumulates zinc levels 10-15 times higher than those in other soft tissues via specialized citrate transporters. Zinc is a potent antimicrobial agent that protects the male reproductive tract from ascending infections. In prostate cancer, cells lose the ability to accumulate zinc, leading to citrate depletion and a shift in cellular metabolism from citrate production to citrate oxidation, which provides energy for malignant growth.
  • Polyamine Synthesis: The prostate secretes spermine, which gives semen its characteristic odor and serves to stabilize sperm DNA, protecting it from oxidative stress.
Icon 1 LIV Hospital

The Spectrum of Prostatic Pathologies

At Liv Hospital, we conceptualize prostate health as a continuum, categorizing diseases into three distinct but occasionally co-existing clinical entities.

Benign Prostatic Hyperplasia (BPH)

BPH is a histological diagnosis characterized by the non-malignant, unregulated proliferation of the stromal and epithelial cells within the Transition Zone. It is the most common benign tumor in men and a near-universal consequence of aging.

  • Molecular Pathogenesis: The development of BPH requires aging and the presence of functioning testes. Testosterone diffuses into prostate cells, where it is converted by the nuclear enzyme 5-alpha-reductase (Type 2) into Dihydrotestosterone (DHT). DHT is a “super-androgen” that binds to the androgen receptor with significantly higher affinity than testosterone. This binding triggers the transcription of growth factors, including Fibroblast Growth Factor (FGF), Epidermal Growth Factor (EGF), and Insulin-like Growth Factor (IGF). These factors drive cellular proliferation and, crucially, inhibit apoptosis (programmed cell death), leading to a net accumulation of tissue.
  • The Role of Inflammation: Emerging evidence suggests that chronic inflammation (M1/M2 macrophage infiltration) plays a key role in BPH progression. Metabolic syndrome and autoimmune responses can trigger stromal cell proliferation via cytokine release (IL-6, IL-8).
  • Obstructive Mechanisms: BPH obstructs urine flow via two distinct mechanisms. The Static Component refers to the sheer physical bulk of the enlarged adenoma, narrowing the urethral lumen. The Dynamic Component refers to the tension of smooth muscle fibers in the prostate stroma and bladder neck. These fibers are rich in alpha-1 adrenergic receptors and contract in response to sympathetic nervous system stimulation, actively squeezing the urethra.

Prostatitis (Inflammatory Disease)

Prostatitis is a heterogeneous group of infectious, inflammatory, and neuropathic disorders. Unlike BPH and cancer, which are diseases of the elderly, prostatitis is the most common urologic diagnosis in men under 50 years of age.

  • The Blood-Prostate Barrier: The epithelial cells lining the prostatic acini are joined by tight junctions, forming a barrier similar to the blood-brain barrier. This prevents many antibiotics from penetrating the gland effectively. This anatomical barrier explains why bacterial prostatitis requires prolonged treatment courses (often 4 to 6 weeks) with lipophilic antibiotics (like fluoroquinolones) to ensure eradication.
  • Chronic Pelvic Pain Syndrome (CPPS): The vast majority (90%) of prostatitis cases are non-bacterial (Category III). The pathophysiology involves neuromuscular tension in the pelvic floor (levator ani spasm), central sensitization of the nervous system (neuroplasticity, where nerves become hypersensitive), and local neurogenic inflammation, rather than an active bacterial infection.

Prostate Cancer (Adenocarcinoma)

Prostate Diseases

Prostate cancer is the uncontrolled malignant proliferation of epithelial cells, typically arising in the Peripheral Zone. It is the second most frequently diagnosed cancer in men worldwide and a significant cause of cancer mortality.

  • Biological Heterogeneity: Prostate cancer is unique in its variability. Many tumors are “indolent” (clinically insignificant), growing so slowly that they will never spread, cause symptoms, or shorten the patient’s life. These patients die with prostate cancer, not of it. Conversely, other tumors are “aggressive” (clinically significant), with a tendency for early dedifferentiation and metastasis to the pelvic lymph nodes and the axial skeleton (osteoblastic bone metastases). Differentiating between these two types is the primary challenge of modern urologic oncology.
  • Androgen Dependence: Prostate cancer cells retain the physiological dependence on testosterone for growth and survival. This biological fact forms the basis of Androgen Deprivation Therapy (ADT), also known as chemical castration, which is the cornerstone of systemic treatment for advanced disease.
  • Castration Resistance: Over time, cancer cells may evolve mechanisms to survive in a low-testosterone environment, developing into Castration-Resistant Prostate Cancer (CRPC). This involves androgen receptor amplification, mutations, or the development of intracrine androgen synthesis pathways.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches
Assoc. Prof. MD. Buğra Bilge Keseroğlu Assoc. Prof. MD. Buğra Bilge Keseroğlu Urology
Group 346 LIV Hospital

Reviews from 9,651

4,9

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is the difference between Hypertrophy and Hyperplasia in the prostate?

Technically, hypertrophy refers to an increase in the size of individual cells. In contrast, hyperplasia refers to the rise in the number of cells. BPH is a true hyperplasia in which the number of stromal and epithelial cells increases significantly due to reduced cell death and increased cell division, leading to the gland growing physically larger.

No epidemiological evidence suggests that BPH leads to cancer. They are separate conditions arising in different zones of the prostate (the Transition Zone for BPH vs. the Peripheral Zone for Cancer) and driven by distinct molecular pathways. However, because they share risk factors like aging and hormonal drive, they often coexist in the same patient.

The prostate accumulates zinc levels 10 to 15 times higher than other soft tissues via specialized transporters. Zinc acts as a potent antimicrobial agent, protecting the urinary tract and the reproductive system from ascending infection. In prostate cancer, cells lose the ability to accumulate zinc, leading to a shift in cellular metabolism that provides energy for tumor growth.

As BPH tissue (adenoma) grows in the central transition zone, it pushes the normal peripheral zone tissue outward, compressing it into a thin, fibrous, and condensed shell known as the surgical capsule. During surgeries like TURP or Open Prostatectomy, surgeons peel the BPH tissue away from this capsule, leaving the outer shell intact. This explains why prostate cancer can still develop in the remaining tissue after BPH surgery.

Biological females do not have a prostate gland. They possess Skene’s glands (paraurethral glands), which are embryologically homologous to the prostate and can occasionally become infected or form cysts. Still, they do not develop BPH or typical prostate adenocarcinoma.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Let's Talk About Your Health

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

How helpful was it?

helpful
helpful
helpful
Your Comparison List (you must select at least 2 packages)